TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 49 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,701,000 | +2.5% | 1,710,000 | 0.0% | 0.00% | – |
Q3 2020 | $1,660,000 | +0.2% | 1,710,000 | 0.0% | 0.00% | – |
Q2 2020 | $1,656,000 | +11.1% | 1,710,000 | +6.2% | 0.00% | – |
Q1 2020 | $1,490,000 | +2.4% | 1,610,000 | +4.9% | 0.00% | – |
Q4 2019 | $1,455,000 | -7.4% | 1,535,000 | -11.5% | 0.00% | – |
Q3 2019 | $1,571,000 | +34.7% | 1,735,000 | +36.1% | 0.00% | – |
Q2 2019 | $1,166,000 | -0.8% | 1,275,000 | 0.0% | 0.00% | – |
Q1 2019 | $1,175,000 | +15.8% | 1,275,000 | +13.3% | 0.00% | – |
Q4 2018 | $1,015,000 | +17.3% | 1,125,000 | +21.6% | 0.00% | – |
Q3 2018 | $865,000 | +28.7% | 925,000 | +27.6% | 0.00% | – |
Q2 2018 | $672,000 | -21.4% | 725,000 | -25.6% | 0.00% | – |
Q1 2018 | $855,000 | -39.4% | 975,000 | -39.4% | 0.00% | – |
Q4 2017 | $1,411,000 | -2.6% | 1,608,000 | 0.0% | 0.00% | – |
Q3 2017 | $1,449,000 | +78.2% | 1,608,000 | +112.1% | 0.00% | – |
Q2 2017 | $813,000 | +26.2% | 758,000 | +26.3% | 0.00% | – |
Q1 2017 | $644,000 | – | 600,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |